194 related articles for article (PubMed ID: 18045548)
21. MR imaging in rat glioma model and gene therapy using EGFR antisence RNA.
Zhang Y; Cui J; Liu X; Pu P; Wang G; Wu E
Chin Med J (Engl); 1998 Nov; 111(11):993-7. PubMed ID: 11189225
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic effect of 125IUdR on the glioma cell line C6 in vitro and in vivo].
Wu B; You C; Liu XD; Cai BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):671-4. PubMed ID: 15460416
[TBL] [Abstract][Full Text] [Related]
23. Quantification and distribution of neovascularization following microinjection of C6 glioma cells in rat brain.
Péoc'h M; Le Duc G; Trayaud A; Farion R; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 1999; 19(4B):3025-30. PubMed ID: 10652587
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of intra-tumoral angiogenesis and glioma growth by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate.
Cuevas P; Carceller F; Reimers D; Cuevas B; Lozano RM; Giménez-Gallego G
Neurol Res; 1999 Jul; 21(5):481-7. PubMed ID: 10439429
[TBL] [Abstract][Full Text] [Related]
25. Using behavioral measurement to assess tumor progression and functional outcome after antiangiogenic treatment in mouse glioma models.
Yang H; Chopp M; Zhang X; Jiang F; Zhang Z; Kalkanis S; Schallert T
Behav Brain Res; 2007 Aug; 182(1):42-50. PubMed ID: 17572515
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging.
Goldbrunner RH; Bendszus M; Sasaki M; Kraemer T; Plate KH; Roosen K; Tonn JC
Neurosurgery; 2000 Oct; 47(4):921-9; discussion 929-30. PubMed ID: 11014432
[TBL] [Abstract][Full Text] [Related]
28. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
29. [Rat model for the multidrug resistant glioma cell line].
Zhang J; Zhang QL; Wang CW; Yu TF; Guo H; Kong JX; Tao RJ; Liu FS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):43-6. PubMed ID: 15052773
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19).
Spaeth N; Wyss MT; Pahnke J; Biollaz G; Trachsel E; Drandarov K; Treyer V; Weber B; Neri D; Buck A
Nucl Med Biol; 2006 Jul; 33(5):661-6. PubMed ID: 16843841
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis and gliomas: current issues and development of surrogate markers.
Jouanneau E
Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890
[TBL] [Abstract][Full Text] [Related]
32. Localization of endostatin in rat and human gliomas.
Strik HM; Schluesener HJ; Seid K; Meyermann R; Deininger MH
Cancer; 2001 Mar; 91(5):1013-9. PubMed ID: 11251954
[TBL] [Abstract][Full Text] [Related]
33. Undersulfation of glycosaminoglycans induced by sodium chlorate treatment affects the progression of C6 rat glioma, in-vivo.
Lobão-Soares B; Alvarez-Silva M; Mendes de Aguiar CB; Nicolau M; Trentin AG
Brain Res; 2007 Feb; 1131(1):29-36. PubMed ID: 17174944
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
35. Development of an arterial tree in C6 gliomas but not in A375 melanomas.
Papoutsi M; Othman-Hassan K; Christ B; Patel K; Wilting J
Histochem Cell Biol; 2002 Sep; 118(3):241-9. PubMed ID: 12271360
[TBL] [Abstract][Full Text] [Related]
36. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA.
Lin CY; Siow TY; Lin MH; Hsu YH; Tung YY; Jang T; Recht L; Chang C
Angiogenesis; 2013 Oct; 16(4):785-93. PubMed ID: 23736837
[TBL] [Abstract][Full Text] [Related]
37. Endogenous growth inhibition of angiogenesis in brain tumors.
Kirsch M; Allende R; Black P; Schackert G
Cancer Metastasis Rev; 2007 Dec; 26(3-4):469-79. PubMed ID: 17960325
[TBL] [Abstract][Full Text] [Related]
38. OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.
de Souza PC; Balasubramanian K; Njoku C; Smith N; Gillespie DL; Schwager A; Abdullah O; Ritchey JW; Fung KM; Saunders D; Jensen RL; Towner RA
J Magn Reson Imaging; 2015 Dec; 42(6):1582-91. PubMed ID: 25920494
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
[TBL] [Abstract][Full Text] [Related]
40. Enhanced expression of the high affinity glutamate transporter GLT-1 in C6 glioma cells delays tumour progression in rat.
Vanhoutte N; Abarca-Quinones J; Jordan BF; Gallez B; Maloteaux JM; Hermans E
Exp Neurol; 2009 Jul; 218(1):56-63. PubMed ID: 19374901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
